Navigation Links
Emerson Resources Expands Pharmaceutical Development and Analytical Capabilities
Date:8/13/2014

Norristown, Pennsylvania (PRWEB) August 13, 2014

Emerson Resources, Inc., a premier pharmaceutical development company, today announced the expansion of its formulation development, clinical supplies manufacturing, and analytical capabilities. The Company now offers feasibility and pilot scale spray drying for drug solubility enhancement, as well as a more robust analytical offering, via the addition of a new solid-state characterization laboratory. This growth reflects the Company’s focus on delivering pragmatic yet creative solutions to its clients, through the use of cutting-edge technologies and application of innovative problem solving.

The Company’s robust suite of pharmaceutical manufacturing equipment now features two Spray Dryers, the Buchi B290 Spray Dryer and the GEA Mobile Minor, both of which are closed-loop for organic solvents. The Mobile Minor is equipped with two-fluid and pressure nozzle spray systems to accommodate a wide range of applications.

As well as expanding its manufacturing capabilities, Emerson Resources has added a solid-state characterization laboratory to its 46,000 square foot facility, which will enable Emerson to better meet the analytical needs of its clients. The new laboratory includes a wide range of technologies such as TA Instruments Q2000 Modulated Differential Scanning Calorimeter (mDSC), JEOL Neoscope JCM-6000 Scanning Electron Microscope (SEM), Rigaku MiniFlex 600 X-Ray Diffractometer (XRD) and the Malvern Mastersizer 3000 Particle Size Analyzer (PSA).

“Drug solubility enhancement will be the key to unlocking the potential of many future therapies. Our investment in these new capabilities underscores our commitment to quickly and efficiently driving the development of these therapies,” said Rob Tuohy, Sr. Vice President & Chief Scientific Officer. “Our recent expansion, combined with our established track record of creativity, flexibility, and quality, will undoubtedly support the measurable success of our clients.”

                                                             ####

About Emerson Resources
For more than 12 years, Emerson Resources, a premier pharmaceutical development company, has delivered value-added service, ingredients and expertise to clients in the pharmaceutical and biotech industries. Emerson Resources is a leader in dosage form development, manufacturing cGMP clinical supplies, analytical method development, analytical method validation, release testing and stability testing. Based in Norristown, Pennsylvania, the Company’s expansive facility features development and analytical laboratories, a cGMP clinical supplies manufacturing plant, and a specialty ingredients excipients manufacturing center. For more information, visit http://www.emersonresources.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12084444.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Emerson Resources Announces CEO Retirement and Appointment of Successor
2. Cepheid Welcomes Senior Vice President of Human Resources
3. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
4. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
5. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
6. Wiley Job Network Announces New Resources and Tools to Connect Job Seekers and Employers
7. ClearPath Workforce Management Expert to Present on Contractor Payroll, Engagement and Compliance as Part of Institute for Human Resources Virtual Conference
8. Energy Briefing - Advancing Energy Companies Progressing This Week: Alternative Fuels Americas, Pacific Ethanol, Halcón Resources, Exxon, Kodiak Oil & Gas
9. Decision Resources Group Acquires Relay Technology Management
10. Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition
11. UV Flu Technologies Expands Its International Footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):